Literature DB >> 29785559

Childbirth after adolescent and young adult cancer: a population-based study.

Hazel B Nichols1, Chelsea Anderson2, Kathryn J Ruddy3, Kristin Z Black4, Barbara Luke5, Stephanie M Engel2, Jennifer E Mersereau6.   

Abstract

PURPOSE: Annually, > 45,000 US women are diagnosed with cancer during adolescence and young adulthood (AYA). Since 2006, national guidelines have recommended fertility counseling for cancer patients. We examined childbirth after AYA cancer by calendar period, cancer diagnosis, and maternal characteristics.
METHODS: We identified a cohort of women with an incident invasive AYA cancer diagnosis at ages 15-39 during 2000-2013 in North Carolina. Cancer records were linked with statewide birth certificates through 2014. Hazard ratios (HR) and 95% confidence intervals (CI) for first post-diagnosis live birth were calculated using Cox proportional hazards regression.
RESULTS: Among 17,564 AYA cancer survivors, 1989 had ≥ 1 birth after diagnosis during 98,397 person-years. The 5- and 10-year cumulative incidence of live birth after cancer was 10 and 15%, respectively. AYA survivors with a post-diagnosis birth were younger at diagnosis, had lower stage disease, and had less often received chemotherapy than those without a birth. The 5-year cumulative incidence of post-diagnosis birth was 10.0% for women diagnosed during 2007-2012, compared to 9.4% during 2000-2005 (HR = 1.01; 0.91, 1.12), corresponding to periods before and after publication of American Society of Clinical Oncology fertility counseling guidelines in 2006.
CONCLUSIONS: Despite advances in fertility preservation options and recognition of fertility counseling as a part of high-quality cancer care, the incidence of post-diagnosis childbirth has remained stable over the last 15 years. IMPLICATIONS FOR CANCER SURVIVORS: Our study uses statewide data to provide recent, population-based estimates of how often AYA women have biological children after a cancer diagnosis.

Entities:  

Keywords:  Adolescent; Live birth; Neoplasms; Survivors; Young adult

Mesh:

Year:  2018        PMID: 29785559      PMCID: PMC6511987          DOI: 10.1007/s11764-018-0695-7

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  35 in total

1.  Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation.

Authors:  Lisa Campo-Engelstein
Journal:  J Clin Oncol       Date:  2010-02-08       Impact factor: 44.544

2.  Contraceptive Practices Among Female Cancer Survivors of Reproductive Age.

Authors:  Sally A Dominick; Mamie R McLean; Brian W Whitcomb; Jessica R Gorman; Jennifer E Mersereau; Janet M Bouknight; H Irene Su
Journal:  Obstet Gynecol       Date:  2015-09       Impact factor: 7.661

3.  Cancer Survivors' Use of Fertility Preservation.

Authors:  Carla M Bann; Katherine Treiman; Linda Squiers; Janice Tzeng; Stephanie Nutt; Sarah Arvey; Devon McGoldrick; Ruth Rechis
Journal:  J Womens Health (Larchmt)       Date:  2015-09-16       Impact factor: 2.681

4.  Trends of socioeconomic disparities in referral patterns for fertility preservation consultation.

Authors:  Linnea R Goodman; Ursula Balthazar; Jayeon Kim; Jennifer E Mersereau
Journal:  Hum Reprod       Date:  2012-05-02       Impact factor: 6.918

5.  Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report.

Authors:  Sophie D Fosså; Henriette Magelssen; Kari Melve; Anne B Jacobsen; Frøydis Langmark; Rolv Skjaerven
Journal:  J Natl Cancer Inst Monogr       Date:  2005

Review 6.  Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Alison W Loren; Pamela B Mangu; Lindsay Nohr Beck; Lawrence Brennan; Anthony J Magdalinski; Ann H Partridge; Gwendolyn Quinn; W Hamish Wallace; Kutluk Oktay
Journal:  J Clin Oncol       Date:  2013-05-28       Impact factor: 44.544

7.  Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis.

Authors:  Beth A Mueller; Eric J Chow; Aruna Kamineni; Janet R Daling; Alison Fraser; Charles L Wiggins; Geraldine P Mineau; Merlin R Hamre; Richard K Severson; Carolyn Drews-Botsch
Journal:  Arch Pediatr Adolesc Med       Date:  2009-10

8.  Adolescent and young adult oncology. Clinical practice guidelines in oncology.

Authors:  Peter F Coccia; Jessica Altman; Smita Bhatia; Scott C Borinstein; Joseph Flynn; Suzanne George; Robert Goldsby; Robert Hayashi; Mary S Huang; Rebecca H Johnson; Lynda Kwon Beaupin; Michael P Link; Kevin C Oeffinger; Kathleen M Orr; Alberto S Pappo; Damon Reed; Holly L Spraker; Deborah A Thomas; Margaret von Mehren; Daniel S Wechsler; Kimberly F Whelan; Bradley J Zebrack; Hema Sundar; Dorothy A Shead
Journal:  J Natl Compr Canc Netw       Date:  2012-09       Impact factor: 11.908

9.  Risk Assessment of Adverse Birth Outcomes in Relation to Maternal Age.

Authors:  Yi-Hao Weng; Chun-Yuh Yang; Ya-Wen Chiu
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

10.  Adverse obstetric and perinatal outcomes following treatment of adolescent and young adult cancer: a population-based cohort study.

Authors:  Fatima A Haggar; Gavin Pereira; David Preen; C D'Arcy Holman; Kristjana Einarsdottir
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

View more
  2 in total

1.  Obstetrical and Perinatal Outcomes in Female Survivors of Childhood and Adolescent Cancer: A Population-Based Cohort Study.

Authors:  Alina Zgardau; Joel G Ray; Nancy N Baxter; Chenthila Nagamuthu; Alison L Park; Sumit Gupta; Paul C Nathan
Journal:  J Natl Cancer Inst       Date:  2022-04-11       Impact factor: 13.506

2.  The Adolescent and Young Adult (AYA) Horizon Study: An AYA Cancer Survivorship Cohort.

Authors:  Chun R Chao; Lawrence H Kushi; Hazel B Nichols; Chris D Baggett; Stephanie M Engel; Darios Getahun; Chelsea Anderson; Nancy T Cannizzaro; Laura Green; Parul Gupta; Cecile A Laurent; Paul C Lin; Clare Meernik; Lisa M Moy; Ethan Wantman; Lanfang Xu; Marilyn L Kwan; Jennifer E Mersereau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-02-22       Impact factor: 4.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.